ADAR1, inosine and the immune sensing system: Distinguishing self from non-self

Wiley Interdisciplinary Reviews: RNA

Volumn 7, Issue 2, 2016, Pages 157-172

  Liddicoat, Brian J ^a,b   Chalk, Alistair M ^a,b   Walkley, Carl R ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA 1; DOUBLE STRANDED RNA; INOSINE; INTERFERON; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; ADAR1 PROTEIN, HUMAN; IFIH1 PROTEIN, HUMAN; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; RETROPOSON; RNA BINDING PROTEIN; VIRUS RNA;

CANCER GROWTH; ENZYME ACTIVITY; GENETIC ANALYSIS; HUMAN; IMMUNE SYSTEM; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR PATHOLOGY; MOLECULAR RECOGNITION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RETROPOSON; REVIEW; RNA EDITING; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL MODEL; DISEASE PREDISPOSITION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TRANSCRIPTION INITIATION;

ADENOSINE DEAMINASE; ANIMALS; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GENOME-WIDE ASSOCIATION STUDY; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; INOSINE; INTERFERON-INDUCED HELICASE, IFIH1; INTERFERONS; MODELS, ANIMAL; PHENOTYPE; RETROELEMENTS; RNA EDITING; RNA, DOUBLE-STRANDED; RNA, VIRAL; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84958885957     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1322     Document Type: Review

References (98)

1. RADAR: a rigorously annotated database of A-to-I RNA editing (http://rnaedit.com/).
2. Ramaswami G, Li JB. RADAR: a rigorously annotated database of A-to-I RNA editing. Nucleic Acids Res 2014, 42:D109-D113.
3. DARNED database (Database of RNA editing in flies, mice and humans; http://darned.ucc.ie/).
4. Kiran AM, O'Mahony JJ, Sanjeev K, Baranov PV. Darned in 2013: inclusion of model organisms and linking with Wikipedia. Nucleic Acids Res 2013 Jan, 41(Database issue):D258-D261. doi:10.1093/nar/gks961.
5. Knisbacher BA, Levanon EY. DNA and RNA editing of retrotransposons accelerate mammalian genome evolution. Ann N Y Acad Sci 2015 Apr, 1341:115-125. doi:10.1111/nyas.12713.
6. Levanon EY, Eisenberg E. Does RNA editing compensate for Alu invasion of the primate genome? Bioessays 2015 Feb, 37:175-181.
7. Mattick JS. RNA as the substrate for epigenome-environment interactions: RNA guidance of epigenetic processes and the expansion of RNA editing in animals underpins development, phenotypic plasticity, learning, and cognition. Bioessays 2010 Jul, 32:548-552. doi:10.1002/bies.201000028.
8. Hundley HA, Bass BL. ADAR editing in double-stranded UTRs and other noncoding RNA sequences. Trends Biochem Sci 2010 Jul, 35:377-383. doi:10.1016/j.tibs.2010.02.008.
9. Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol 2014 Jan, 14:36-49. doi:10.1038/nri3581.
10. Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol 2015 Jul, 15:429-440. doi:10.1038/nri3850.
11. Bass BL, Weintraub H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 1988, 55:1089-1098. doi:10.1016/0092-8674(88)90253-X.
12. Ramaswami G, Lin W, Piskol R, Tan MH, Davis C, Li JB. Accurate identification of human Alu and non-Alu RNA editing sites. Nat Methods 2012, 9:579-581. doi:10.1038/nmeth.1982.
13. Eggington JM, Greene T, Bass BL. Predicting sites of ADAR editing in double-stranded RNA. Nat Commun 2011, 2:319. doi:10.1038/ncomms1324.
14. Rueda P, Garcia-Barreno B, Melero JA. Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). Virology 1994, 198:653-662. doi:10.1006/viro.1994.1077.
15. Wang JG, Cullen J, Lemon SM. Immunoblot analysis demonstrates that the large and small forms of hepatitis delta virus antigen have different C-terminal amino acid sequences. J Gen Virol 1992, 73(Pt 1):183-188. doi:10.1099/0022-1317-73-1-183.
16. Ekdahl Y, Farahani HS, Behm M, Lagergren J, Ohman M. A-to-I editing of microRNAs in the mammalian brain increases during development. Genome Res 2012, 22:1477-1487. doi:10.1101/gr.131912.111.
17. Rueter SM, Dawson TR, Emeson RB. Regulation of alternative splicing by RNA editing. Nature 1999, 399:75-80. doi:10.1038/19992.
18. Higuchi M, Single FN, Kohler M, Sommer B, Sprengel R, Seeburg PH. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 1993, 75:1361-1370.
19. Bazak L, Haviv A, Barak M, Jacob-Hirsch J, Deng P, Zhang R, Isaacs FJ, Rechavi G, Li JB, Eisenberg E, et al. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res 2014, 24:365-376. doi:10.1101/gr.164749.113.
20. Li JB, Levanon EY, Yoon JK, Aach J, Xie B, Leproust E, Zhang K, Gao Y, Church GM. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 2009, 324:1210-1213. doi:10.1126/science.1170995.
21. Wu J, Chen ZJ. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 2014, 32:461-488. doi:10.1146/annurev-immunol-032713-120156.
22. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820. doi:10.1016/j.cell.2010.01.022.
23. Ablasser A, Hemmerling I, Schmid-Burgk JL, Behrendt R, Roers A, Hornung V. TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J Immunol 2014, 192:5993-5997. doi:10.4049/jimmunol.1400737.
24. White MJ, McArthur K, Metcalf D, Lane RM, Cambier JC, Herold MJ, van Delft MF, Bedoui S, Lessene G, Ritchie ME, et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 2014, 159:1549-1562. doi:10.1016/j.cell.2014.11.036.
25. Rongvaux A, Jackson R, Harman CC, Li T, West AP, de Zoete MR, Wu Y, Yordy B, Lakhani SA, Kuan CY, et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 2014, 159:1563-1577. doi:10.1016/j.cell.2014.11.037.
26. Bernard JJ, Cowing-Zitron C, Nakatsuji T, Muehleisen B, Muto J, Borkowski AW, Martinez L, Greidinger EL, Yu BD, Gallo RL. Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat Med 2012, 18:1286-1290. doi:10.1038/nm.2861.
27. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 2006, 314:997-1001. doi:10.1126/science.1132998.
28. Shatkin AJ, Manley JL. The ends of the affair: capping and polyadenylation. Nat Struct Biol 2000, 7:838-842. doi:10.1038/79583.
29. Banerjee AK. 5′-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev 1980, 44:175-205.
30. Goubau D, Schlee M, Deddouche S, Pruijssers AJ, Zillinger T, Goldeck M, Schuberth C, Van der Veen AG, Fujimura T, Rehwinkel J, et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates. Nature 2014, 514:372-375. doi:10.1038/nature13590.
31. Vitali P, Scadden AD. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat Struct Mol Biol 2010, 17:1043-1050. doi:10.1038/nsmb.1864.
32. Bass BL, Weintraub H. A developmentally regulated activity that unwinds RNA duplexes. Cell 1987, 48:607-613. doi:10.1016/0092-8674(87)90239-X.
33. Rebagliati MR, Melton DA. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 1987, 48:599-605. doi:10.1016/0092-8674(87)90238-8.
34. Wagner RW, Smith JE, Cooperman BS, Nishikura K. A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proc Natl Acad Sci U S A 1989, 86:2647-2651.
35. Sommer B, Kohler M, Sprengel R, Seeburg PH. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 1991, 67:11-19. doi:10.1016/0092-8674(91)90568-J.
36. Melcher T, Maas S, Herb A, Sprengel R, Seeburg PH, Higuchi M. A mammalian RNA editing enzyme. Nature 1996, 379:460-464. doi:10.1038/379460a0.
37. Melcher T, Maas S, Herb A, Sprengel R, Higuchi M, Seeburg PH. RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J Biol Chem 1996, 271:31795-31798. doi:10.1074/jbc.271.50.31795.
38. Patterson JB, Samuel CE. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol 1995, 15:5376-5388.
39. George CX, Samuel CE. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc Natl Acad Sci U S A 1999, 96:4621-4626. doi:10.1073/pnas.96.8.4621.
40. Keegan LP, McGurk L, Palavicini JP, Brindle J, Paro S, Li X, Rosenthal JJ, O'Connell MA. Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects. Nucleic Acids Res 2011, 39:7249-7262. doi:10.1093/nar/gkr423.
41. Hartner JC, Schmittwolf C, Kispert A, Muller AM, Higuchi M, Seeburg PH. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 2004, 279:4894-4902. doi:10.1074/jbc.M311347200.
42. Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000, 406:78-81. doi:10.1038/35017558.
43. Hideyama T, Yamashita T, Aizawa H, Tsuji S, Kakita A, Takahashi H, Kwak S. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiol Dis 2012, 45:1121-1128. doi:10.1016/j.nbd.2011.12.033.
44. Palladino MJ, Keegan LP, O'Connell MA, Reenan RA. A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity. Cell 2000, 102:437-449. doi:10.1016/S0092-8674(00)00049-0.
45. Yamashita T, Kwak S. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients. Brain Res 2014, 1584:28-38. doi:10.1016/j.brainres.2013.12.011.
46. Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 2004, 279:4952-4961. doi:10.1074/jbc.M310162200.
47. Hartner JC, Walkley CR, Lu J, Orkin SH. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol 2009, 10:109-115. doi:10.1038/ni.1680.
48. Liddicoat BJ, Piskol R, Chalk AM, Ramaswami G, Higuchi M, Hartner JC, Li JB, Seeburg PH, Walkley CR. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 2015, 349:1115-1120. doi:10.1126/science.aac7049.
49. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 2006, 80:5059-5064. doi:10.1128/JVI.80.10.5059-5064.2006.
50. Tomaselli S, Galeano F, Locatelli F, Gallo A. ADARs and the balance game between virus infection and innate immune cell response. Curr Issues Mol Biol 2014, 17:37-52.
51. Samuel CE. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology 2011, 411:180-193. doi:10.1016/j.virol.2010.12.004.
52. Gu R, Zhang Z, DeCerbo JN, Carmichael GG. Gene regulation by sense-antisense overlap of polyadenylation signals. RNA 2009, 15:1154-1163. doi:10.1261/rna.1608909.
53. George CX, Samuel CE. Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2. J Virol 2011, 85:8338-8347. doi:10.1128/JVI.02666-10.
54. Nie Y, Hammond GL, Yang JH. Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. J Virol 2007, 81:917-923. doi:10.1128/JVI.01527-06.
55. O'Hara PJ, Nichol ST, Horodyski FM, Holland JJ. Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell 1984, 36:915-924. doi:10.1016/0092-8674(84)90041-2.
56. Murphy DG, Dimock K, Kang CY. Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology 1991, 181:760-763.
57. Cattaneo R, Schmid A, Eschle D, Baczko K, ter Meulen V, Billeter MA. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 1988, 55:255-265. doi:10.1016/0092-8674(88)90048-7.
58. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott WJ Jr, Potter SS. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991, 65:677-689. doi:10.1016/0092-8674(91)90099-K.
59. Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J 2003, 22:4478-4488. doi:10.1093/emboj/cdg434.
60. Ward SV, George CX, Welch MJ, Liou LY, Hahm B, Lewicki H, de la Torre JC, Samuel CE, Oldstone MB. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc Natl Acad Sci U S A 2011, 108:331-336. doi:10.1073/pnas.1017241108.
61. XuFeng R, Boyer MJ, Shen H, Li Y, Yu H, Gao Y, Yang Q, Wang Q, Cheng T. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc Natl Acad Sci U S A 2009, 106:17763-17768. doi:10.1073/pnas.0903324106.
62. Yu S, Sharma R, Nie D, Jiao H, Im HJ, Lai Y, Zhao Z, Zhu K, Fan J, Chen D, et al. ADAR1 ablation decreases bone mass by impairing osteoblast function in mice. Gene 2013, 513:101-110. doi:10.1016/j.gene.2012.10.068.
63. Qiu W, Wang X, Buchanan M, He K, Sharma R, Zhang L, Wang Q, Yu J. ADAR1 is essential for intestinal homeostasis and stem cell maintenance. Cell Death Dis 2013, 4:e599. doi:10.1038/cddis.2013.125.
64. Sharma R, Wang Y, Zhou P, Steinman RA, Wang Q. An essential role of RNA editing enzyme ADAR1 in mouse skin. J Dermatol Sci 2011, 64:70-72. doi:10.1016/j.jdermsci.2011.06.013.
65. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421. doi:10.1126/science.8197455.
66. Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, Chapman R, Hertzog PJ. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 2013, 41:D1040-D1046. doi:10.1093/nar/gks1215.
67. Li Z, Okonski KM, Samuel CE. Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus. J Virol 2012, 86:3787-3794.
68. Li Z, Wolff KC, Samuel CE. RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment. Virology 2010, 396:316-322. doi:10.1016/j.virol.2009.10.026.
69. Washburn MC, Kakaradov B, Sundararaman B, Wheeler E, Hoon S, Yeo GW, Hundley HA. The dsRBP and inactive editor ADR-1 utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome. Cell Rep 2014, 6:599-607. doi:10.1016/j.celrep.2014.01.011.
70. Koeris M, Funke L, Shrestha J, Rich A, Maas S. Modulation of ADAR1 editing activity by Z-RNA in vitro. Nucleic Acids Res 2005, 33:5362-5370. doi:10.1093/nar/gki849.
71. Feng S, Li H, Zhao J, Pervushin K, Lowenhaupt K, Schwartz TU, Droge P. Alternate rRNA secondary structures as regulators of translation. Nat Struct Mol Biol 2011, 18:169-176. doi:10.1038/nsmb.1962.
72. Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, Iizasa H, Davuluri RV, Nishikura K. ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell 2013, 153:575-589. doi:10.1016/j.cell.2013.03.024.
73. Mannion NM, Greenwood SM, Young R, Cox S, Brindle J, Read D, Nellaker C, Vesely C, Ponting CP, McLaughlin PJ, et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 2014, 9:1482-1494. doi:10.1016/j.celrep.2014.10.041.
74. Baron MH, Isern J, Fraser ST. The embryonic origins of erythropoiesis in mammals. Blood 2012, 119:4828-4837. doi:10.1182/blood-2012-01-153486.
75. Perkins AC, Sharpe AH, Orkin SH. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 1995, 375:318-322. doi:10.1038/375318a0.
76. Seita J, Sahoo D, Rossi DJ, Bhattacharya D, Serwold T, Inlay MA, Ehrlich LI, Fathman JW, Dill DL, Weissman IL. Gene expression commons: an open platform for absolute gene expression profiling. PLoS One 2012, 7:e40321. doi:10.1371/journal.pone.0040321.
77. Nejepinska J, Malik R, Filkowski J, Flemr M, Filipowicz W, Svoboda P. dsRNA expression in the mouse elicits RNAi in oocytes and low adenosine deamination in somatic cells. Nucleic Acids Res 2012, 40:399-413. doi:10.1093/nar/gkr702.
78. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6:981-988. doi:10.1038/ni1243.
79. Wu B, Peisley A, Richards C, Yao H, Zeng X, Lin C, Chu F, Walz T, Hur S. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289. doi:10.1016/j.cell.2012.11.048.
80. Wu B, Hur S. How RIG-I like receptors activate MAVS. Curr Opin Virol 2015, 12:91-98. doi:10.1016/j.coviro.2015.04.004.
81. del Toro DY, Wu B, Hur S. MDA5-filament, dynamics and disease. Curr Opin Virol 2015, 12:20-25. doi:10.1016/j.coviro.2015.01.011.
82. Peisley A, Jo MH, Lin C, Wu B, Orme-Johnson M, Walz T, Hohng S, Hur S. Kinetic mechanism for viral dsRNA length discrimination by MDA5 filaments. Proc Natl Acad Sci U S A 2012, 109:E3340-E3349. doi:10.1073/pnas.1208618109.
83. Barry G, Mattick JS. The role of regulatory RNA in cognitive evolution. Trends Cogn Sci 2012, 16:497-503. doi:10.1016/j.tics.2012.08.007.
84. Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet 2012, 44:1243-1248. doi:10.1038/ng.2414.
85. Crow YJ, Manel N. Aicardi-Goutieres syndrome and the type I interferonopathies. Nat Rev Immunol 2015, 15:429-440. doi:10.1038/nri3850.
86. Rice GI, del Toro DY, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, Bader-Meunier B, Baildam EM, Battini R, Beresford MW, et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 2014, 46:503-509. doi:10.1038/ng.2933.
87. Beghini A, Ripamonti CB, Peterlongo P, Roversi G, Cairoli R, Morra E, Larizza L. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum Mol Genet 2000, 9:2297-2304.
88. Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, Liu M, Yuan YF, Fu L, Kong KL, et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 2013, 19:209-216. doi:10.1038/nm.3043.
89. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813. doi:10.1038/nature08489.
90. Jiang Q, Crews LA, Barrett CL, Chun HJ, Court AC, Isquith JM, Zipeto MA, Goff DJ, Minden M, Sadarangani A, et al. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Proc Natl Acad Sci U S A 2013, 110:1041-1046. doi:10.1073/pnas.1213021110.
91. Steinman RA, Yang Q, Gasparetto M, Robinson LJ, Liu X, Lenzner DE, Hou J, Smith C, Wang Q. Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice. Int J Cancer 2013, 132:1741-1750. doi:10.1002/ijc.27851.
92. Kujawski LA, Talpaz M. The role of interferon-alpha in the treatment of chronic myeloid leukemia. Cytokine Growth Factor Rev 2007, 18:459-471. doi:10.1016/j.cytogfr.2007.06.015.
93. Fumagalli D, Gacquer D, Rothe F, Lefort A, Libert F, Brown D, Kheddoumi N, Shlien A, Konopka T, Salgado R, et al. Principles governing A-to-I RNA editing in the breast cancer transcriptome. Cell Rep 2015, 13:277-289. doi:10.1016/j.celrep.2015.09.032.
94. Han L, Diao L, Yu S, Xu X, Li J, Zhang R, Yang Y, Werner HM, Eterovic AK, Yuan Y, et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell 2015, 28:515-528. doi:10.1016/j.ccell.2015.08.013.
95. Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, Eisenberg E, Levanon EY. Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors. Cell Rep 2015, 13:267-276. doi:10.1016/j.celrep.2015.08.080.
96. Tubio JM, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, Gundem G, Pipinikas CP, Zamora J, Raine K, et al. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science 2014, 345:1251343. doi:10.1126/science.1251343.
97. Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, Han H, Liang G, Jones PA, Pugh TJ, et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell 2015, 162:961-973. doi:10.1016/j.cell.2015.07.056.
98. Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A, et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 2015, 162:974-986. doi:10.1016/j.cell.2015.07.011.